News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeoVax Labs Inc. (GOVX.OB) and VGX International Announce Agreement at the Las Vegas “International Society of DNA Vaccines” Conference



12/8/2008 12:22:22 PM

LAS VEGAS--(BUSINESS WIRE)--GeoVax Labs, Inc. (OTCBB:GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, together with VGX International (VGXI), announced today at the International Society of DNA Vaccines Conference, held in Las Vegas, Nevada, the execution of a Master Product Sale Agreement between VGXI and GeoVax, whereby VGXI will manufacture plasmid, namely the JS2-DNA vaccine, for use in GeoVax’s future preventative and therapeutic clinical human trials.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES